Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we …

Sectors: Biotechnology

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical

Illumina for Startups inspires the creation, funding, and growth of genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include • Startups Grants for founders to work with Illumina sites globally to run proof-of-concept sequencing experiments and • Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, founded in 2021. https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company …

Sectors: Biotechnology Startup accelerator & VC

Solving massive challenges is possible when the world's best startups and industry leaders work together. Headquartered in the United States with eight locations worldwide, MassChallenge equips bold entrepreneurs to disrupt the status quo and create sustainable change. Startups, Business Competition, Accelerator Program, and Entrepreneurship

Sectors: Startup accelerator & VC

A unique platform specialized in tech investments #avp #axaventurepartners #tech #vc AVP (AXA Venture Partners) is a venture capital fund investing in high-growth, technology-enabled companies. AVP has built a unique investment platform specialized in tech investments with $1.2bn of assets under management through three pillars of investment expertise: Early Stage Fund, Growth Stage Fund and Fund of Funds. To date, AVP has invested in more than 60+ Early and Growth equity deals and 35+ Fund investments. AVP team operates globally backed by offices in Paris, London and New York. Beyond investments, AVP provides access to business development opportunities helping portfolio …

Sectors: Startup accelerator & VC

#WeareBiotech Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world …

Sectors: Biotechnology

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, …

Sectors: Startup accelerator & VC

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. We are driven by the excitement of building technologies, inventing products, and providing services that change lives. We embrace new ways of doing things, make decisions quickly, and are not afraid to fail. We have the scope and capabilities of a large company, and the spirit and heart of a small one. Together, Amazonians research and develop new technologies from Amazon Web Services to Alexa on behalf of our customers: shoppers, sellers, content creators, and developers around the …

Sectors: Consumer Electronics IT services

[Automatic translation follows] Share the economy. Associating the expertise of a historical title to the agility of digital, the Tribune has operated for several years its transformation, deploying at the heart of the uses of its audience: website, digital daily, mobile applications, social networks, butAlso a field presence to animate its audience via the organization of 80 events per year.Its territorial anchor makes the tribune the economic media of metropolises with editions in regions and Africa with the African gallery, fueling an editorial line focused on the real economy (innovation, digital, territories ...) and enhance thecompanies that boost their ecosystem.

Sectors: Media

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank